Search Videos and More
2025 Practice-Changing Updates in Bladder, Kidney & Prostate Cancer
Evolving Evidence in Radiation Oncology
International Kidney Cancer Collaboration with Leadership from Philadelphia
Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050Our Motto: Professional, Personable, and Proactive
“As the front line of a patient’s journey, our front desk and surgery scheduling teams play a crucial role in shaping each patient’s first impression of the Fox Chase Cancer Center – Temple Health brand within our urology outpatient clinics. Every encounter must be professional, personable, and proactive, as it sets the tone for the patient’s entire experience with us,” said Natasha Varela, Administrative Manager for four Fox Chase – Temple Urologic Institute outpatient clinics.Connecting Across Continents: From Philadelphia to Kigali
When Samuel Ivan, MD chose a Reconstructive and Prosthetic Urology Fellowship at Fox Chase, his goal was to train with Fellowship Director Jay Simhan MD, FACS, Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University—a renowned urologic reconstructive surgeon and clinician whose work and research are globally recognized.The Multi-Institutional Hematopathology Interesting Case Conference: A Brain Trust That Impacts Cancer Diagnoses Worldwide
The foundation of every cancer diagnosis starts behind the scenes, where a pathologist and a team of specialists painstakingly evaluate a patient’s molecular, cytogenetic, and flow cytometry testing to determine whether the individual has cancer, and if so, precisely what type of malignancy, its stage, and how extensive the cancer may be.Fox Chase Radiation Oncology Strikes Gold with ASTRO 2025 Research
Moving sophisticated clinical ideas into the mainstream is a Fox Chase hallmark. Nowhere was that more evident than at this year’s ASTRO, in the city of the Golden Gate Bridge, where research from Fox Chase radiation oncology residents moved the needle for adaptive radiation therapy and other essential modalities, demonstrating superior outcomes and less toxicity.Fox Chase Cancer Center and Temple Researchers Highlight Need for Molecular Testing in Diagnosing Two Types of Kidney Cancer
Genetic testing may be the most effective way for researchers to distinguish between a rare form of kidney cancer and another that is more common, potentially preventing misdiagnoses, according to a recent study by researchers at Fox Chase Cancer Center and Temple University Hospital.Fox Chase – Temple Urologic Institute’s Jennifer Kelly Becomes First Temple Health Nurse to Earn Certification from Society of Urologic Nurses & Associates
Jennifer Kelly, BSN, RN, CURN, a nurse with the Fox Chase-Temple Urologic Institute, has become the first nurse in the Temple Health system to earn certification from the Society of Urologic Nurses & Associates (SUNA).Newer Radiation Technique Reduces Side Effects While Maintaining Effectiveness
Researchers at Fox Chase Cancer Center have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while maintaining treatment effectiveness for patients with esophageal cancer and non-small cell lung cancer.Beyond the Routine – Adapt or Not?
Challenges and Dilemmas in Adaptive Radiation Treatment PlanningAdaptive Radiation Therapy Increases Safety and Preserves Quality of Life, Says Study
For patients with recurrent retroperitoneal sarcomas that cannot be treated surgically, treatment choices are limited. These tumors can grow quite large in the abdomen adjacent to vital organs or enmeshed within the bowel.

